| The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerBRN2 Is an AR-Suppressed Driver of NEPC JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ... Cancer discovery 7 (1), 54-71, 2017 | 284* | 2017 |
| PD-L1 is highly expressed in Enzalutamide resistant prostate cancer JL Bishop, A Sio, A Angeles, ME Roberts, AA Azad, KN Chi, A Zoubeidi Oncotarget 6 (1), 234, 2015 | 252 | 2015 |
| Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate CancerRole of Hsp27 in EMT and Prostate Cancer Metastasis M Shiota, JL Bishop, KM Nip, A Zardan, A Takeuchi, T Cordonnier, ... Cancer research 73 (10), 3109-3119, 2013 | 214 | 2013 |
| Salmonella: from Pathogenesis to Therapeutics EC Boyle, JL Bishop, GA Grassl, BB Finlay Journal of bacteriology 189 (5), 1489-1495, 2007 | 194 | 2007 |
| Subversion of the innate immune system by a retrovirus BA Jude, Y Pobezinskaya, J Bishop, S Parke, RM Medzhitov, ... Nature immunology 4 (6), 573-578, 2003 | 190 | 2003 |
| The multifaceted roles of STAT3 signaling in the progression of prostate cancer JL Bishop, D Thaper, A Zoubeidi Cancers 6 (2), 829-859, 2014 | 128 | 2014 |
| Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ... Prostate cancer and prostatic diseases 20 (1), 28-35, 2017 | 116 | 2017 |
| A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In VivoEfficacy of Compound 30 in MDV3100-Resistant … H Kuruma, H Matsumoto, M Shiota, J Bishop, F Lamoureux, C Thomas, ... Molecular cancer therapeutics 12 (5), 567-576, 2013 | 114 | 2013 |
| Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ... Genome biology 15 (8), 1-14, 2014 | 92 | 2014 |
| SseL Is a Salmonella-Specific Translocated Effector Integrated into the SsrB-Controlled Salmonella Pathogenicity Island 2 Type III Secretion System BK Coombes, MJ Lowden, JL Bishop, ME Wickham, NF Brown, N Duong, ... Infection and immunity 75 (2), 574-580, 2007 | 90 | 2007 |
| Salmonella phage ST64B encodes a member of the SseK/NleB effector family NF Brown, BK Coombes, JL Bishop, ME Wickham, MJ Lowden, O Gal-Mor, ... PLoS One 6 (3), e17824, 2011 | 73 | 2011 |
| Hsp27 regulates EGF/β‐catenin mediated epithelial to mesenchymal transition in prostate cancer T Cordonnier, JL Bishop, M Shiota, KM Nip, D Thaper, S Vahid, D Heroux, ... International Journal of Cancer 136 (6), E496-E507, 2015 | 71 | 2015 |
| Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance M Nouri, J Caradec, AA Lubik, N Li, BG Hollier, M Takhar, ... Oncotarget 8 (12), 18949, 2017 | 64 | 2017 |
| Regulation of tumor cell plasticity by the androgen receptor in prostate cancer JL Bishop, A Davies, K Ketola, A Zoubeidi Endocr Relat Cancer 22 (3), R165-R182, 2015 | 55 | 2015 |
| Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer S Vahid, D Thaper, KF Gibson, JL Bishop, A Zoubeidi Scientific reports 6 (1), 1-12, 2016 | 46 | 2016 |
| An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer A Davies, S Nouruzi, D Ganguli, T Namekawa, D Thaper, S Linder, ... Nature cell biology 23 (9), 1023-1034, 2021 | 44 | 2021 |
| Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer M Shiota, JL Bishop, A Takeuchi, KM Nip, T Cordonnier, E Beraldi, ... Oncotarget 6 (11), 9086, 2015 | 43 | 2015 |
| Friend or foe? Antimicrobial peptides trigger pathogen virulence JL Bishop, BB Finlay Trends in molecular medicine 12 (1), 3-6, 2006 | 40 | 2006 |
| Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer A Zardan, KM Nip, D Thaper, P Toren, S Vahid, E Beraldi, L Fazli, ... Oncogenesis 3 (8), e115-e115, 2014 | 35 | 2014 |
| Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer D Thaper, S Vahid, R Kaur, S Kumar, S Nouruzi, JL Bishop, M Johansson, ... Scientific reports 8 (1), 1-9, 2018 | 32 | 2018 |
